MYH7 and cardiac hypertrophy: To explore potential therapeutic drugs for cardiac hypertrophy and HF, our study screened the effects of FDA-approved chemical compounds library on the transcriptional activity of Myh7 and Bnp based on luciferase reporter assays (Figure 1A).